Literature DB >> 21850036

O-GlcNAc signalling: implications for cancer cell biology.

Chad Slawson1, Gerald W Hart.   

Abstract

O-GlcNAcylation is the covalent attachment of β-D-N-acetylglucosamine (GlcNAc) sugars to serine or threonine residues of nuclear and cytoplasmic proteins, and it is involved in extensive crosstalk with other post-translational modifications, such as phosphorylation. O-GlcNAcylation is becoming increasing realized as having important roles in cancer-relevant processes, such as cell signalling, transcription, cell division, metabolism and cytoskeletal regulation. However, currently little is known about the specific roles of aberrant O-GlcNAcylation in cancer. In this Opinion article, we summarize the current understanding of O-GlcNAcylation in cancer and its emerging functions in transcriptional regulation at the level of chromatin and transcription factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850036      PMCID: PMC3291174          DOI: 10.1038/nrc3114

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  93 in total

1.  Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.

Authors:  Connie Chao; Deron Herr; Jerold Chun; Yang Xu
Journal:  EMBO J       Date:  2006-06-01       Impact factor: 11.598

2.  Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis.

Authors:  Chad Slawson; Natasha E Zachara; Keith Vosseller; Win D Cheung; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

3.  Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination.

Authors:  Lorin E Olson; Jessica Tollkuhn; Claudio Scafoglio; Anna Krones; Jie Zhang; Kenneth A Ohgi; Wei Wu; Makoto M Taketo; Rolf Kemler; Rudolf Grosschedl; Dave Rose; Xue Li; Michael G Rosenfeld
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

4.  Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.

Authors:  Michael T Hemann; Anka Bric; Julie Teruya-Feldstein; Andreas Herbst; Jonas A Nilsson; Carlos Cordon-Cardo; John L Cleveland; William P Tansey; Scott W Lowe
Journal:  Nature       Date:  2005-08-11       Impact factor: 49.962

5.  Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.

Authors:  Thomas R Whisenhunt; Xiaoyong Yang; Damon B Bowe; Andrew J Paterson; Brian A Van Tine; Jeffrey E Kudlow
Journal:  Glycobiology       Date:  2006-02-27       Impact factor: 4.313

6.  Alternative O-GlcNAcylation/O-phosphorylation of Ser16 induce different conformational disturbances to the N terminus of murine estrogen receptor beta.

Authors:  Yong-Xiang Chen; Jin-Tang Du; Lian-Xiu Zhou; Xiao-Hong Liu; Yu-Fen Zhao; Hiroshi Nakanishi; Yan-Mei Li
Journal:  Chem Biol       Date:  2006-09

7.  Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing.

Authors:  Ru Cao; Yu-Ichi Tsukada; Yi Zhang
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

8.  Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants.

Authors:  Naniye Cetinbaş; Matthew S Macauley; Keith A Stubbs; Robert Drapala; David J Vocadlo
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

9.  Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila.

Authors:  Sascha Mendjan; Mikko Taipale; Jop Kind; Herbert Holz; Philipp Gebhardt; Malgorzata Schelder; Michiel Vermeulen; Alessia Buscaino; Kent Duncan; Juerg Mueller; Matthias Wilm; Henk G Stunnenberg; Harald Saumweber; Asifa Akhtar
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

10.  Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.

Authors:  Francesco V Rao; Helge C Dorfmueller; Fabrizio Villa; Matthew Allwood; Ian M Eggleston; Daan M F van Aalten
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

View more
  178 in total

1.  Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.

Authors:  Hannes Hahne; Amin Moghaddas Gholami; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2012-06-01       Impact factor: 5.911

2.  Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.

Authors:  Haitham A Badr; Dina M M AlSadek; Mohit P Mathew; Chen-Zhong Li; Leyla B Djansugurova; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2015-08-10       Impact factor: 12.479

Review 3.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

Review 4.  Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.

Authors:  Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-24       Impact factor: 46.802

5.  O-GlcNAcylation of cofilin promotes breast cancer cell invasion.

Authors:  Xun Huang; Qiuming Pan; Danni Sun; Wei Chen; Aijun Shen; Min Huang; Jian Ding; Meiyu Geng
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

6.  Aspartate Residues Far from the Active Site Drive O-GlcNAc Transferase Substrate Selection.

Authors:  Cassandra M Joiner; Zebulon G Levine; Chanat Aonbangkhen; Christina M Woo; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2019-08-07       Impact factor: 15.419

Review 7.  Glycosylation and stem cells: Regulatory roles and application of iPSCs in the study of glycosylation-related disorders.

Authors:  Ryan P Berger; Michelle Dookwah; Richard Steet; Stephen Dalton
Journal:  Bioessays       Date:  2016-09-26       Impact factor: 4.345

Review 8.  Structural characterization of the O-GlcNAc cycling enzymes: insights into substrate recognition and catalytic mechanisms.

Authors:  Cassandra M Joiner; Hao Li; Jiaoyang Jiang; Suzanne Walker
Journal:  Curr Opin Struct Biol       Date:  2019-01-30       Impact factor: 6.809

Review 9.  Chemoenzymatic Methods for the Synthesis of Glycoproteins.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Chem Rev       Date:  2018-08-24       Impact factor: 60.622

10.  Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.

Authors:  Sara E S Martin; Zhi-Wei Tan; Harri M Itkonen; Damien Y Duveau; Joao A Paulo; John Janetzko; Paul L Boutz; Lisa Törk; Frederick A Moss; Craig J Thomas; Steven P Gygi; Michael B Lazarus; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2018-10-04       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.